Dr. Sende Wellness Semaglutide & Tirzepatide Weight Loss Injections

Dr. Sende Wellness operates as a telehealth-focused weight loss clinic serving patients throughout Florida, led by Dr. Fernando Fandiño-Sende, a double board-certified physician holding certifications in both Cardiovascular Disease and Internal Medicine. The Miami-based practice centers its clinical model on GLP-1 receptor agonist therapy, specifically prescribing and monitoring Semaglutide and Tirzepatide injections for patients seeking medically supervised weight reduction. Dr. Fandiño-Sende's dual cardiology and internal medicine background informs the clinic's approach to weight management, particularly for patients whose cardiovascular health intersects with metabolic concerns. The telehealth delivery model eliminates geographic barriers within Florida, allowing patients across the state to access prescription weight loss medications without requiring in-person office visits for routine consultations and follow-up care.

The clinic's treatment protocol revolves around two FDA-approved GLP-1 medications: Semaglutide, which mimics the incretin hormone to regulate appetite and glucose metabolism, and Tirzepatide, a dual GIP/GLP-1 receptor agonist that activates both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 pathways. Dr. Sende Wellness structures its programs to include not only the injectable medications but also nutritional guidance and exercise planning as integral components of the weight loss strategy. Patients receive individualized dosing schedules that typically begin with lower doses and titrate upward based on tolerance and response, a protocol designed to minimize gastrointestinal side effects commonly associated with GLP-1 therapies. The clinic also addresses hormone optimization as part of its service offering, recognizing that hormonal imbalances frequently contribute to weight gain and metabolic dysfunction, particularly in patients approaching or experiencing perimenopause, menopause, or andropause.

Dr. Fandiño-Sende's cardiovascular training provides a clinical advantage when evaluating candidates for GLP-1 therapy, as he assesses each patient's cardiac risk profile, blood pressure patterns, and existing cardiovascular conditions before initiating treatment. His internal medicine certification enables comprehensive evaluation of comorbidities including type 2 diabetes, hypertension, dyslipidemia, and fatty liver disease—conditions that often improve alongside weight reduction. The clinic's medical supervision extends throughout the treatment course, with regular check-ins to monitor weight trends, adjust medication dosing, address side effects, and modify nutritional or exercise recommendations. This physician-led oversight distinguishes the practice from non-medical weight loss programs, ensuring that patients with complex medical histories receive appropriate screening and ongoing monitoring.

Patients initiating care with Dr. Sende Wellness begin with a telehealth consultation during which medical history, current medications, weight loss goals, and previous weight management attempts are reviewed. The clinic conducts eligibility screening to identify contraindications to GLP-1 therapy, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Once approved for treatment, patients receive their prescribed Semaglutide or Tirzepatide with detailed injection instructions, and the clinic provides ongoing support for questions related to medication administration, dietary modifications, and exercise implementation. The practice emphasizes healthy eating patterns rather than restrictive dieting, and exercise recommendations are tailored to individual fitness levels and physical limitations. Follow-up consultations occur at regular intervals to assess progress, troubleshoot challenges, and determine appropriate treatment duration.

Dr. Sende Wellness maintains a 4.9-star rating across 36 Google reviews, with patients frequently noting the accessibility of the care team, the clarity of the treatment plan, and the responsiveness to questions throughout the weight loss process. The telehealth model offers particular convenience for Florida residents in areas outside Miami who would otherwise face travel barriers to access physician-supervised GLP-1 therapy. The clinic's focus remains narrow and specialized—delivering evidence-based pharmacologic weight loss interventions under the guidance of a cardiologist who understands the interconnected nature of obesity, metabolic disease, and cardiovascular risk. For patients seeking prescription weight loss medication with medical oversight and integrated lifestyle support, Dr. Sende Wellness provides a structured, physician-directed program accessible entirely through virtual care platforms.